(ADN1) Adesso SE - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000A0Z23Q5
Stock: IT Services, IT Solutions, Consulting, Software Development
Total Rating 27
Risk 73
Buy Signal -0.18
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.82% |
| Yield on Cost 5y | 0.62% |
| Yield CAGR 5y | 9.59% |
| Payout Consistency | 99.1% |
| Payout Ratio | 75.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 40.0% |
| Relative Tail Risk | -7.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.55 |
| Alpha | -28.08 |
| Character TTM | |
|---|---|
| Beta | 0.121 |
| Beta Downside | 0.208 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.77% |
| CAGR/Max DD | -0.34 |
Description: ADN1 Adesso SE December 26, 2025
adesso SE (XETRA:ADN1) is a German-headquartered IT services firm founded in 1997, operating in Germany, Austria, Switzerland and globally through two segments: IT Services (consulting, application management, security, digital experience) and IT Solutions (software product distribution and industry-neutral platforms). The company serves a broad client base across automotive, banking, utilities, healthcare, retail, life sciences, media, public sector and insurance.
Recent financials (FY 2023) show revenue of €1.6 bn, up ~5 % YoY, with an EBITDA margin of roughly 9 %-reflecting steady demand for digital transformation projects in regulated sectors. The firm’s “SmartShore” near-shore delivery model has helped contain labor cost inflation, a key driver given the broader European IT talent shortage.
Sector-wide, the German IT outsourcing market is projected to grow 4-5 % annually through 2027, powered by mandatory cybersecurity upgrades and the push for cloud-native architectures in the automotive and financial services industries-areas where adesso holds established expertise.
For a deeper quantitative assessment, you may find ValueRay’s platform useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 13.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -6.14 > 1.0 |
| NWC/Revenue: 6.92% < 20% (prev 4.51%; Δ 2.40% < -1%) |
| CFO/TA 0.08 > 3% & CFO 68.9m > Net Income 13.4m |
| Net Debt (323.1m) to EBITDA (112.4m): 2.88 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (6.40m) vs 12m ago -1.80% < -2% |
| Gross Margin: 13.38% > 18% (prev 0.14%; Δ 1324 % > 0.5%) |
| Asset Turnover: 173.2% > 50% (prev 159.9%; Δ 13.30% > 0%) |
| Interest Coverage Ratio: 2.87 > 6 (EBITDA TTM 112.4m / Interest Expense TTM 13.7m) |
Altman Z'' 2.15
| A: 0.12 (Total Current Assets 427.0m - Total Current Liabilities 328.7m) / Total Assets 851.4m |
| B: 0.18 (Retained Earnings 151.0m / Total Assets 851.4m) |
| C: 0.05 (EBIT TTM 39.4m / Avg Total Assets 821.1m) |
| D: 0.47 (Book Value of Equity 308.6m / Total Liabilities 657.1m) |
| Altman-Z'' Score: 2.15 = BBB |
Beneish M -2.94
| DSRI: 1.02 (Receivables 349.3m/304.0m, Revenue 1.42b/1.26b) |
| GMI: 1.05 (GM 13.38% / 14.11%) |
| AQI: 1.00 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.12 (Revenue 1.42b / 1.26b) |
| TATA: -0.07 (NI 13.4m - CFO 68.9m) / TA 851.4m) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of ADN1 shares?
As of February 08, 2026, the stock is trading at EUR 72.00 with a total of 11,536 shares traded.
Over the past week, the price has changed by -11.44%, over one month by -19.19%, over three months by -21.05% and over the past year by -24.20%.
Over the past week, the price has changed by -11.44%, over one month by -19.19%, over three months by -21.05% and over the past year by -24.20%.
Is ADN1 a buy, sell or hold?
Adesso SE has no consensus analysts rating.
What are the forecasts/targets for the ADN1 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 127.8 | 77.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 62.3 | -13.5% |
ADN1 Fundamental Data Overview February 02, 2026
Market Cap USD = 614.1m (520.4m EUR * 1.1801 EUR.USD)
P/E Trailing = 43.2447
P/S = 0.3643
P/B = 2.9001
Revenue TTM = 1.42b EUR
EBIT TTM = 39.4m EUR
EBITDA TTM = 112.4m EUR
Long Term Debt = 158.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 62.1m EUR (from shortTermDebt, last quarter)
Debt = 368.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 323.1m EUR (from netDebt column, last quarter)
Enterprise Value = 843.6m EUR (520.4m + Debt 368.3m - CCE 45.2m)
Interest Coverage Ratio = 2.87 (Ebit TTM 39.4m / Interest Expense TTM 13.7m)
EV/FCF = 15.38x (Enterprise Value 843.6m / FCF TTM 54.9m)
FCF Yield = 6.50% (FCF TTM 54.9m / Enterprise Value 843.6m)
FCF Margin = 3.86% (FCF TTM 54.9m / Revenue TTM 1.42b)
Net Margin = 0.94% (Net Income TTM 13.4m / Revenue TTM 1.42b)
Gross Margin = 13.38% ((Revenue TTM 1.42b - Cost of Revenue TTM 1.23b) / Revenue TTM)
Gross Margin QoQ = 14.65% (prev 10.74%)
Tobins Q-Ratio = 0.99 (Enterprise Value 843.6m / Total Assets 851.4m)
Interest Expense / Debt = 0.90% (Interest Expense 3.31m / Debt 368.3m)
Taxrate = 30.30% (5.29m / 17.5m)
NOPAT = 27.4m (EBIT 39.4m * (1 - 30.30%))
Current Ratio = 1.30 (Total Current Assets 427.0m / Total Current Liabilities 328.7m)
Debt / Equity = 1.93 (Debt 368.3m / totalStockholderEquity, last quarter 191.1m)
Debt / EBITDA = 2.88 (Net Debt 323.1m / EBITDA 112.4m)
Debt / FCF = 5.89 (Net Debt 323.1m / FCF TTM 54.9m)
Total Stockholder Equity = 185.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.63% (Net Income 13.4m / Total Assets 851.4m)
RoE = 7.22% (Net Income TTM 13.4m / Total Stockholder Equity 185.9m)
RoCE = 11.43% (EBIT 39.4m / Capital Employed (Equity 185.9m + L.T.Debt 158.6m))
RoIC = 15.41% (NOPAT 27.4m / Invested Capital 178.1m)
WACC = 3.98% (E(520.4m)/V(888.7m) * Re(6.36%) + D(368.3m)/V(888.7m) * Rd(0.90%) * (1-Tc(0.30)))
Discount Rate = 6.36% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.90%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈72.7m ; Y1≈47.7m ; Y5≈21.8m
Fair Price DCF = 57.95 (EV 694.1m - Net Debt 323.1m = Equity 371.0m / Shares 6.40m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -32.51 | EPS CAGR: -9.91% | SUE: -0.33 | # QB: 0
Revenue Correlation: 96.56 | Revenue CAGR: 21.20% | SUE: 0.11 | # QB: 0
EPS next Year (2026-12-31): EPS=5.78 | Chg30d=+0.299 | Revisions Net=-1 | Growth EPS=+76.0% | Growth Revenue=+10.4%
P/E Trailing = 43.2447
P/S = 0.3643
P/B = 2.9001
Revenue TTM = 1.42b EUR
EBIT TTM = 39.4m EUR
EBITDA TTM = 112.4m EUR
Long Term Debt = 158.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 62.1m EUR (from shortTermDebt, last quarter)
Debt = 368.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 323.1m EUR (from netDebt column, last quarter)
Enterprise Value = 843.6m EUR (520.4m + Debt 368.3m - CCE 45.2m)
Interest Coverage Ratio = 2.87 (Ebit TTM 39.4m / Interest Expense TTM 13.7m)
EV/FCF = 15.38x (Enterprise Value 843.6m / FCF TTM 54.9m)
FCF Yield = 6.50% (FCF TTM 54.9m / Enterprise Value 843.6m)
FCF Margin = 3.86% (FCF TTM 54.9m / Revenue TTM 1.42b)
Net Margin = 0.94% (Net Income TTM 13.4m / Revenue TTM 1.42b)
Gross Margin = 13.38% ((Revenue TTM 1.42b - Cost of Revenue TTM 1.23b) / Revenue TTM)
Gross Margin QoQ = 14.65% (prev 10.74%)
Tobins Q-Ratio = 0.99 (Enterprise Value 843.6m / Total Assets 851.4m)
Interest Expense / Debt = 0.90% (Interest Expense 3.31m / Debt 368.3m)
Taxrate = 30.30% (5.29m / 17.5m)
NOPAT = 27.4m (EBIT 39.4m * (1 - 30.30%))
Current Ratio = 1.30 (Total Current Assets 427.0m / Total Current Liabilities 328.7m)
Debt / Equity = 1.93 (Debt 368.3m / totalStockholderEquity, last quarter 191.1m)
Debt / EBITDA = 2.88 (Net Debt 323.1m / EBITDA 112.4m)
Debt / FCF = 5.89 (Net Debt 323.1m / FCF TTM 54.9m)
Total Stockholder Equity = 185.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.63% (Net Income 13.4m / Total Assets 851.4m)
RoE = 7.22% (Net Income TTM 13.4m / Total Stockholder Equity 185.9m)
RoCE = 11.43% (EBIT 39.4m / Capital Employed (Equity 185.9m + L.T.Debt 158.6m))
RoIC = 15.41% (NOPAT 27.4m / Invested Capital 178.1m)
WACC = 3.98% (E(520.4m)/V(888.7m) * Re(6.36%) + D(368.3m)/V(888.7m) * Rd(0.90%) * (1-Tc(0.30)))
Discount Rate = 6.36% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.90%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈72.7m ; Y1≈47.7m ; Y5≈21.8m
Fair Price DCF = 57.95 (EV 694.1m - Net Debt 323.1m = Equity 371.0m / Shares 6.40m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -32.51 | EPS CAGR: -9.91% | SUE: -0.33 | # QB: 0
Revenue Correlation: 96.56 | Revenue CAGR: 21.20% | SUE: 0.11 | # QB: 0
EPS next Year (2026-12-31): EPS=5.78 | Chg30d=+0.299 | Revisions Net=-1 | Growth EPS=+76.0% | Growth Revenue=+10.4%